Table 3 The AUC of each symptom associated with the clinical outcome of COVID-19.
From: Risk factors associated with the severity of COVID-19 in a region of the Brazilian Amazon
Variables | AUC | Std. errora | p-value | IC: 95% confidence interval | |
|---|---|---|---|---|---|
Lower bound | Upper bound | ||||
Age | 0.873 | 0.003 | < 0.0001 | 0.868 | 0.879 |
Dyspnea | 0.756 | 0.003 | < 0.0001 | 0.750 | 0.762 |
Cough | 0.581 | 0.004 | < 0.0001 | 0.574 | 0.589 |
Sex | 0.580 | 0.004 | < 0.0001 | 0.572 | 0.588 |
Fever | 0.550 | 0.004 | < 0.0001 | 0.542 | 0.558 |
Nausea | 0.508 | 0.004 | 0.053 | 0.500 | 0.517 |
Nasal_congestion | 0.498 | 0.004 | 0.614 | 0.490 | 0.506 |
Adynamia | 0.494 | 0.004 | 0.135 | 0.485 | 0.502 |
Coryza | 0.469 | 0.004 | < 0.0001 | 0.461 | 0..477 |
Myalgia arthralgia | 0.451 | 0.004 | < 0.0001 | 0.443 | 0.458 |
Sore throat | 0.430 | 0.004 | < 0.0001 | 0.422 | 0.438 |
Headache | 0.410 | 0.004 | < 0.0001 | 0.403 | 0.418 |